547 related articles for article (PubMed ID: 25940460)
1. Use of selective serotonin reuptake inhibitors and bone mass in adolescents: An NHANES study.
Feuer AJ; Demmer RT; Thai A; Vogiatzi MG
Bone; 2015 Sep; 78():28-33. PubMed ID: 25940460
[TBL] [Abstract][Full Text] [Related]
2. Association of Stimulant Medication Use With Bone Mass in Children and Adolescents With Attention-Deficit/Hyperactivity Disorder.
Feuer AJ; Thai A; Demmer RT; Vogiatzi M
JAMA Pediatr; 2016 Dec; 170(12):e162804. PubMed ID: 27695823
[TBL] [Abstract][Full Text] [Related]
3. Association of low bone mineral density with selective serotonin reuptake inhibitor use by older men.
Haney EM; Chan BK; Diem SJ; Ensrud KE; Cauley JA; Barrett-Connor E; Orwoll E; Bliziotes MM;
Arch Intern Med; 2007 Jun; 167(12):1246-51. PubMed ID: 17592097
[TBL] [Abstract][Full Text] [Related]
4. Rates of bone loss among women initiating antidepressant medication use in midlife.
Diem SJ; Ruppert K; Cauley JA; Lian Y; Bromberger JT; Finkelstein JS; Greendale GA; Solomon DH
J Clin Endocrinol Metab; 2013 Nov; 98(11):4355-63. PubMed ID: 24001746
[TBL] [Abstract][Full Text] [Related]
5. Effect of selective serotonin reuptake inhibitors on bone mineral density: a systematic review and meta-analysis.
Zhou C; Fang L; Chen Y; Zhong J; Wang H; Xie P
Osteoporos Int; 2018 Jun; 29(6):1243-1251. PubMed ID: 29435621
[TBL] [Abstract][Full Text] [Related]
6. A cross-sectional evaluation of the effect of risperidone and selective serotonin reuptake inhibitors on bone mineral density in boys.
Calarge CA; Zimmerman B; Xie D; Kuperman S; Schlechte JA
J Clin Psychiatry; 2010 Mar; 71(3):338-47. PubMed ID: 20331935
[TBL] [Abstract][Full Text] [Related]
7. Examining Whether Genetic Variants Moderate the Skeletal Effects of Selective Serotonin Reuptake Inhibitors in Older Adolescents and Young Adults.
Ezenwabachili I; Deumic Shultz E; Mills JA; Ellingrod V; Calarge CA
J Child Adolesc Psychopharmacol; 2023 Sep; 33(7):260-268. PubMed ID: 37579130
[No Abstract] [Full Text] [Related]
8. Variants of the serotonin transporter gene, selective serotonin reuptake inhibitors, and bone mineral density in risperidone-treated boys: a reanalysis of data from a cross-sectional study with emphasis on pharmacogenetics.
Calarge CA; Ellingrod VL; Zimmerman B; Bliziotes MM; Schlechte JA
J Clin Psychiatry; 2011 Dec; 72(12):1685-90. PubMed ID: 22244026
[TBL] [Abstract][Full Text] [Related]
9. Bone Mineral Density across the Lifespan in Patients with Type 1 Diabetes.
Halper-Stromberg E; Gallo T; Champakanath A; Taki I; Rewers M; Snell-Bergeon J; Frohnert BI; Shah VN
J Clin Endocrinol Metab; 2020 Mar; 105(3):746-53. PubMed ID: 31676897
[TBL] [Abstract][Full Text] [Related]
10. Blood Lead Level Is Negatively Associated With Bone Mineral Density in U.S. Children and Adolescents Aged 8-19 Years.
Cui A; Xiao P; Hu B; Ma Y; Fan Z; Wang H; Zhou F; Zhuang Y
Front Endocrinol (Lausanne); 2022; 13():928752. PubMed ID: 35846292
[TBL] [Abstract][Full Text] [Related]
11. Nutrition status, bone mass density, and selective serotonin reuptake inhibitors.
Kindilien S; Goldberg EM; Roberts MH; Gonzales-Pacheco D
Prev Med; 2018 Aug; 113():62-67. PubMed ID: 29746975
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the effect of selective serotonin reuptake inhibitors on bone mineral density: an observational cross-sectional study.
Ak E; Bulut SD; Bulut S; Akdağ HA; Öter GB; Kaya H; Kaya OB; Şengül CB; Kısa C
Osteoporos Int; 2015 Jan; 26(1):273-9. PubMed ID: 25187118
[TBL] [Abstract][Full Text] [Related]
13. Association of Protein Intake with Bone Mineral Density and Bone Mineral Content among Elderly Women: The OSTPRE Fracture Prevention Study.
Isanejad M; Sirola J; Mursu J; Kröger H; Tuppurainen M; Erkkilä AT
J Nutr Health Aging; 2017; 21(6):622-630. PubMed ID: 28537325
[TBL] [Abstract][Full Text] [Related]
14. Lumbar spine and proximal femur bone mineral density, bone mineral content, and bone area: United States, 2005-2008.
Looker AC; Borrud LG; Hughes JP; Fan B; Shepherd JA; Melton LJ
Vital Health Stat 11; 2012 Mar; (251):1-132. PubMed ID: 24261130
[TBL] [Abstract][Full Text] [Related]
15. Association of Selective Serotonin Reuptake Inhibitors and Bone Mineral Density in Elderly Women.
Saraykar S; John V; Cao B; Hnatow M; Ambrose CG; Rianon N
J Clin Densitom; 2018; 21(2):193-199. PubMed ID: 28712980
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal examination of the skeletal effects of selective serotonin reuptake inhibitors and risperidone in boys.
Calarge CA; Burns TL; Schlechte JA; Zemel BS
J Clin Psychiatry; 2015 May; 76(5):607-13. PubMed ID: 26035190
[TBL] [Abstract][Full Text] [Related]
17. Association between grip strength and bone mineral density in general US population of NHANES 2013-2014.
Luo Y; Jiang K; He M
Arch Osteoporos; 2020 Mar; 15(1):47. PubMed ID: 32173776
[TBL] [Abstract][Full Text] [Related]
18. An investigation of the association between omega 3 FA and bone mineral density among older adults: results from the National Health and Nutrition Examination Survey years 2005–2008.
Mangano KM; Kerstetter JE; Kenny AM; Insogna KL; Walsh SJ
Osteoporos Int; 2014 Mar; 25(3):1033-41. PubMed ID: 24121998
[TBL] [Abstract][Full Text] [Related]
19. An Updated Reference for Calculating Bone Mineral Density T-Scores.
Xue S; Zhang Y; Qiao W; Zhao Q; Guo D; Li B; Shen X; Feng L; Huang F; Wang N; Oumer KS; Getachew CT; Yang S
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2613-e2621. PubMed ID: 33735391
[TBL] [Abstract][Full Text] [Related]
20. Normal Bone Microstructure and Density But Worse Physical Function in Older Women Treated with Selective Serotonin Reuptake Inhibitors, a Cross-Sectional Population-Based Study.
Larsson B; Mellström D; Johansson L; Nilsson AG; Lorentzon M; Sundh D
Calcif Tissue Int; 2018 Sep; 103(3):278-288. PubMed ID: 29730704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
